课题基金 / 基金详情

REGULATION OF INNATE IMMUNITY TO ENTEROCYTOZOON BIENEUSI INFECTION

REGULATION OF INNATE IMMUNITY TO ENTEROCYTOZOON BIENEUSI INFECTION
对肠细胞虫感染的先天免疫的调节
批准号:
7958373
负责人:
SAUL r TZIPORI
金额:
$11.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30

项目摘要

项目成果

SAUL r TZIPORI的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 从SIV感染的动物收集粪便并分析Eb孢子的存在,从中纯化它们用于实验室研究:1)来自人和恒河猴的比氏肠细胞虫的比较:相似性和差异; 2)对纯化的Eb孢子的体外或体内先天免疫应答的表征。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The feces were collected from SIV-infected animals and were analyzed for the presence of Eb spores from which they were purified for laboratory investigations: 1) Comparison of Enterocytozoon bieneusi from Human and Rhesus macaque: Similarities and Differences; 2) Characterization of the innate immune responses in vitro or in vivo to the purified Eb spores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Aptamer-Based Therapy Against HUS
  • 批准号:
    7644745
  • 项目类别:
  • 资助金额:
    $68.11万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
Development of Aptamer-Based Therapy Against HUS
  • 批准号:
    7929518
  • 项目类别:
  • 资助金额:
    $66.47万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
INNATE IMMUNITY OF ENTEROCYTOZOON BIENEUSI (EB) IN VIVO
  • 批准号:
    7715540
  • 项目类别:
  • 资助金额:
    $5.52万
  • 财政年份:
    2008
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
CONTRIBUTION OF OIS TO INTESTINAL DYSFUNCTION AND WASTING
  • 批准号:
    7562006
  • 项目类别:
  • 资助金额:
    $10.36万
  • 财政年份:
    2007
  • 负责人:
    SAUL r TZIPORI
  • 依托单位: